STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 55 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $426,000 | +18.0% | 143,577 | +9.6% | 0.01% | 0.0% |
| Q1 2021 | $361,000 | -46.0% | 130,948 | -52.4% | 0.01% | -44.0% |
| Q4 2020 | $669,000 | -16.1% | 275,337 | -27.4% | 0.02% | -47.9% |
| Q3 2020 | $797,000 | -44.8% | 379,398 | -0.8% | 0.05% | -51.5% |
| Q2 2020 | $1,445,000 | +96.9% | 382,400 | -1.5% | 0.10% | +62.3% |
| Q1 2020 | $734,000 | +95.2% | 388,309 | +223.6% | 0.06% | +79.4% |
| Q2 2019 | $376,000 | -24.5% | 120,000 | +20.0% | 0.03% | -29.2% |
| Q1 2019 | $498,000 | +113.7% | 100,000 | +92.3% | 0.05% | +41.2% |
| Q4 2018 | $233,000 | – | 52,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $15,803,000 | 17.82% |
| Prosight Management, LP | 2,515,072 | $6,011,000 | 3.33% |
| 22NW, LP | 804,410 | $1,923,000 | 2.54% |
| Broadfin Capital, LLC | 2,578,003 | $6,161,000 | 1.14% |
| NEA Management Company, LLC | 4,141,308 | $9,898,000 | 0.82% |
| Opaleye Management Inc. | 490,000 | $1,171,000 | 0.42% |
| PA Capital LLC | 152,977 | $366,000 | 0.36% |
| 683 Capital Management, LLC | 923,700 | $2,208,000 | 0.25% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 414,982 | $992,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,475,000 | $3,525,000 | 0.10% |